{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:43:58Z","timestamp":1768441438465,"version":"3.49.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.gene.2021.146019","type":"journal-article","created":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T04:13:10Z","timestamp":1634184790000},"page":"146019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Glutathione-S-transferase genetic polymorphism and risk of hepatotoxicity to antitubercular drugs in a North-African population: A case-control study"],"prefix":"10.1016","volume":"809","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3476-874X","authenticated-orcid":false,"given":"Chahra","family":"Chbili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neila","family":"Fathallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chayma","family":"Laadhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bouraoui","family":"Ouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad","family":"Saguem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha","family":"Ben Fredj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Abdelghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmi","family":"Ben Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaker","family":"Ben Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2021.146019_b0005","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fgene.2020.00210","article-title":"Hardy-Weinberg equilibrium in the large scale genomic sequencing era","volume":"11","author":"Abramovs","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.gene.2021.146019_b0010","article-title":"A prospective observational study to evaluate Glutathione S-transferase gene polymorphism and its association with Antitubercular drugs induced liver injury in tertiary hospital","author":"Akhtar","year":"2021","journal-title":"Indian J. Tuberc."},{"key":"10.1016\/j.gene.2021.146019_b0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212853","article-title":"Epidemiology and disease burden of tuberculosis in south of Tunisia over a 22-year period: Current trends and future projections","volume":"14","author":"Ben Ayed","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.gene.2021.146019_b0020","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/tpj.2016.26","article-title":"Risk factors of isoniazid-induced hepatotoxicity in Tunisian tuberculosis patients","volume":"17","author":"Ben Fredj","year":"2017","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.gene.2021.146019_b0025","doi-asserted-by":"crossref","first-page":"167","DOI":"10.11604\/pamj.2016.25.167.10060","article-title":"First line anti-tuberculosis induced hepatotoxicity: incidence and risk factors","volume":"25","author":"Bouazzi","year":"2016","journal-title":"Pan. Afr. Med. J."},{"key":"10.1016\/j.gene.2021.146019_b0030","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2710.2009.01101.x","article-title":"GSTT1 and GSTM1 gene deletions are not associated with hepatotoxicity caused by antitubercular drugs","volume":"35","author":"Chatterjee","year":"2010","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.gene.2021.146019_b0035","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.eplepsyres.2014.05.009","article-title":"Effects of glutathione S-transferase M1 and T1 deletions on epilepsy risk among a Tunisian population","volume":"108","author":"Chbili","year":"2014","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.gene.2021.146019_b0040","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3389\/fphar.2019.00853","article-title":"Roussel Uclaf causality assessment method for drug-induced liver injury: Present and future","volume":"10","author":"Danan","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.gene.2021.146019_b0045","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cca.2012.10.030","article-title":"Relationship of NAT2, CYP2E1 and GSTM1\/GSTT1 polymorphisms with mild elevation of liver enzymes in Brazilian individuals under anti-tuberculosis drug therapy","volume":"415","author":"Forestiero","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.gene.2021.146019_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2008.08.006","article-title":"Glutathione: overview of its protective roles, measurement, and biosynthesis","volume":"30","author":"Forman","year":"2009","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.gene.2021.146019_b0055","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/ajg.2009.665","article-title":"Correlation of liver stiffness and histological features in healthy persons and in patients with occult hepatitis B, chronic active hepatitis B, or hepatitis B cirrhosis","volume":"105","author":"Fung","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.gene.2021.146019_b0060","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/1471-2164-9-360","article-title":"A method for detecting epistasis in genome-wide studies using case-control multi-locus association analysis","volume":"9","author":"Gayan","year":"2008","journal-title":"BMC Genomics"},{"key":"10.1016\/j.gene.2021.146019_b0065","first-page":"266","article-title":"The effect of GST M1 and GST T1 gene mutations on anti-tuberculous drug induced hepatic injury","volume":"32","author":"Guo","year":"2009","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"10.1016\/j.gene.2021.146019_b0070","doi-asserted-by":"crossref","unstructured":"Gupta, V.H., Singh, M., Amarapurkar, D.N., Sasi, P., Joshi, J.M., Baijal, R., H, R.P., Amarapurkar, A.D., Joshi, K. and Wangikar, P.P., 2013. Association of GST null genotypes with anti-tuberculosis drug induced hepatotoxicity in Western Indian population. Ann Hepatol 12, 959-65.","DOI":"10.1016\/S1665-2681(19)31302-X"},{"key":"10.1016\/j.gene.2021.146019_b0075","article-title":"Involvement of cytochrome P450 1A1 and glutathione S-transferase P1 polymorphisms and promoter hypermethylation in the progression of anti-tuberculosis drug-induced liver injury: a case-control study","volume":"10","author":"He","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.gene.2021.146019_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17425255.3.1.1","article-title":"Genetic polymorphisms of drug-metabolizing enzymes and the susceptibility to antituberculosis drug-induced liver injury","volume":"3","author":"Huang","year":"2007","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.gene.2021.146019_b0085","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jhep.2007.02.009","article-title":"Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury","volume":"47","author":"Huang","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.gene.2021.146019_b0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tube.2009.12.001","article-title":"GSTT1 and GSTM1 null mutations and adverse reactions induced by antituberculosis drugs in Koreans","volume":"90","author":"Kim","year":"2010","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.gene.2021.146019_b0095","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1155\/2011\/956250","article-title":"Combined analysis of EPHX1, GSTP1, GSTM1 and GSTT1 gene polymorphisms in relation to chronic obstructive pulmonary disease risk and lung function impairment","volume":"30","author":"Lakhdar","year":"2011","journal-title":"Dis. Markers"},{"key":"10.1016\/j.gene.2021.146019_b0100","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1478-3231.2008.01700.x","article-title":"Influence of glutathione S-transferase M1 and T1 homozygous null mutations on the risk of antituberculosis drug-induced hepatotoxicity in a Caucasian population","volume":"28","author":"Leiro","year":"2008","journal-title":"Liver Int."},{"key":"10.1016\/j.gene.2021.146019_b0105","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1038\/s41598-018-23646-2","article-title":"Diagnostic accuracy of liver stiffness measurement in chronic hepatitis B patients with normal or mildly elevated alanine transaminase levels","volume":"8","author":"Li","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2021.146019_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115410","article-title":"Impact of glutathione S-transferase M1 and T1 on anti-tuberculosis drug-induced hepatotoxicity in Chinese pediatric patients","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.gene.2021.146019_b0115","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/hep.22370","article-title":"Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury","volume":"48","author":"Lucena","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.gene.2021.146019_b0120","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.3389\/fphar.2019.01482","article-title":"Drug-induced liver injury: Biomarkers, requirements, candidates, and validation","volume":"10","author":"Meunier","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.gene.2021.146019_b0125","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/pros.20907","article-title":"An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review","volume":"69","author":"Mo","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.gene.2021.146019_b0130","first-page":"534","article-title":"Comparison between serum alpha-glutathione S-transferase and aminotransaminases in detecting cytolysis in hepatitis C-infected children","volume":"28","author":"Namour","year":"1999","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.gene.2021.146019_b0135","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1124\/dmd.111.040469","article-title":"Involvement of different human glutathione transferase isoforms in the glutathione conjugation of reactive metabolites of troglitazone","volume":"39","author":"Okada","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.gene.2021.146019_b0140","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.clinbiochem.2011.05.024","article-title":"GSTP1 mRNA expression in human circulating blood leukocytes is associated with GSTP1 genetic polymorphism","volume":"44","author":"Reszka","year":"2011","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.gene.2021.146019_b0145","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1158\/0008-5472.CAN-03-2861","article-title":"Association of homozygous wild-type glutathione S-transferase M1 genotype with increased breast cancer risk","volume":"64","author":"Roodi","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2021.146019_b0150","first-page":"233","article-title":"Frequencies of GSTM1, GSTT1, and GSTP1 polymorphisms in a Brazilian population","volume":"1","author":"Rossini","year":"2002","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.gene.2021.146019_b0155","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1440-1746.2001.02585.x","article-title":"Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 'null' mutation","volume":"16","author":"Roy","year":"2001","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.gene.2021.146019_b0160","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.2174\/092986709788803097","article-title":"Current concepts of mechanisms in drug-induced hepatotoxicity","volume":"16","author":"Russmann","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.gene.2021.146019_b0165","first-page":"541","article-title":"Genetic polymorphisms (GSTT1 e GSTM1) and urinary excretion of t, t-muconic acid among refinery worker","volume":"29","author":"Sapienza","year":"2007","journal-title":"G. Ital. Med. Lav. Ergon."},{"key":"10.1016\/j.gene.2021.146019_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2161-1068.1000209","article-title":"Current overview of anti-tuberculosis drugs: metabolism and toxicities","volume":"6","author":"Sarkar","year":"2016","journal-title":"Mycobact. Dis."},{"key":"10.1016\/j.gene.2021.146019_b0175","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An official ATS statement: hepatotoxicity of antituberculosis therapy","volume":"174","author":"Saukkonen","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.gene.2021.146019_b0180","first-page":"1","article-title":"Methodological sheet n degrees 1: How to calculate the size of a sample for an observational study?","volume":"98","author":"Serhier","year":"2020","journal-title":"Tunis. Med."},{"key":"10.1016\/j.gene.2021.146019_b0185","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/096032719701600604","article-title":"Study of oxidative-stress in rifampicin-induced hepatic injury in growing rats with and without protein-energy malnutrition","volume":"16","author":"Sodhi","year":"1997","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.gene.2021.146019_b0190","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/01480549809002207","article-title":"Oxidative-hepatic injury of isoniazid-rifampicin in young rats subjected to protein and energy malnutrition","volume":"21","author":"Sodhi","year":"1998","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.gene.2021.146019_b0195","first-page":"803","article-title":"Association of isoniazid-metabolizing enzyme genotypes and isoniazid-induced hepatotoxicity in tuberculosis patients","volume":"25","author":"Sotsuka","year":"2011","journal-title":"In Vivo"},{"key":"10.1016\/j.gene.2021.146019_b0200","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0378-4274(99)00230-1","article-title":"Glutathione S-transferase: genetics and role in toxicology","volume":"112\u2013113","author":"Strange","year":"2000","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.gene.2021.146019_b0205","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5588\/ijtld.12.0447","article-title":"GSTM1 and GSTT1 null polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis","volume":"17","author":"Tang","year":"2013","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.gene.2021.146019_b0210","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2710.2012.01334.x","article-title":"CYP2E1, GSTM1 and GSTT1 genetic polymorphisms and susceptibility to antituberculosis drug-induced hepatotoxicity: a nested case-control study","volume":"37","author":"Tang","year":"2012","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.gene.2021.146019_b0215","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1590\/S0074-02762011000600011","article-title":"Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients","volume":"106","author":"Teixeira","year":"2011","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.gene.2021.146019_b0220","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1471-2164-11-58","article-title":"Does replication groups scoring reduce false positive rate in SNP interaction discovery?","volume":"11","author":"Toplak","year":"2010","journal-title":"BMC Genomics"},{"key":"10.1016\/j.gene.2021.146019_b0225","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1440-1746.2007.05207.x","article-title":"Antituberculosis drug-induced hepatotoxicity: concise up-to-date review","volume":"23","author":"Tostmann","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.gene.2021.146019_b0230","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1038\/sj.onc.1206940","article-title":"The role of glutathione-S-transferase in anti-cancer drug resistance","volume":"22","author":"Townsend","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2021.146019_b0235","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1177\/147323001003800324","article-title":"Genetic polymorphisms of cytochrome P450 and glutathione S-transferase associated with antituberculosis drug-induced hepatotoxicity in Chinese tuberculosis patients","volume":"38","author":"Wang","year":"2010","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.gene.2021.146019_b0240","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/carcin\/19.2.275","article-title":"Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution","volume":"19","author":"Watson","year":"1998","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.gene.2021.146019_b0245","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1055\/s-0028-1109980","article-title":"ALT screening for chronic liver diseases: scrutinizing the evidence","volume":"48","author":"Wedemeyer","year":"2010","journal-title":"Z. Gastroenterol."},{"key":"10.1016\/j.gene.2021.146019_b0250","unstructured":"WHO, 2011. Global tuberculosis control WHO Report. World Health Organization. 2011. Available from this URL: http:\/\/apps.who.int\/iris\/bitstream\/10665\/44728\/1\/9789241564380_eng.pdf (last visit: September 19th 2021)."},{"key":"10.1016\/j.gene.2021.146019_b0255","article-title":"Genetic polymorphisms of Glutathione S-Transferase P1 (GSTP1) and the incidence of anti-tuberculosis drug-induced hepatotoxicity","volume":"11","author":"Wu","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.gene.2021.146019_b0260","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1096\/fj.08-124073","article-title":"A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer","volume":"23","author":"Yu","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.gene.2021.146019_b0265","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1089\/gtmb.2012.0095","article-title":"Cytochrome P450 (CYP3A4*18) and glutathione-S-transferase (GSTP1) polymorphisms in a healthy Tunisian population","volume":"16","author":"Zaied","year":"2012","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"10.1016\/j.gene.2021.146019_b0270","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1432-1033.1994.00893.x","article-title":"Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties","volume":"224","author":"Zimniak","year":"1994","journal-title":"Eur. J. Biochem."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111921006144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111921006144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:45:37Z","timestamp":1759855537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111921006144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":54,"alternative-id":["S0378111921006144"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2021.146019","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glutathione-S-transferase genetic polymorphism and risk of hepatotoxicity to antitubercular drugs in a North-African population: A case-control study","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2021.146019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"146019"}}